生物安全檢測市場規模、佔有率和成長分析（按產品/服務、檢測類型、應用、最終用戶和地區）- 產業預測 2025-2032

生物安全測試市場規模預計在2023年達到52.5億美元，並從2024年的58.6億美元成長到2032年的142.1億美元，預測期內（2025-2032年）的複合年成長率為11.7%。

生物安全測試是確保生物來源的生物製藥和醫療設備安全的重要過程。這種綜合方法旨在透過分析污染和不利的生物效應來評估和減輕潛在風險。遵守嚴格的監管標準對於確保這些材料的純度、效力和整體安全性至關重要。無菌測試、內毒素評估和細胞化驗分析等關鍵技術在評估是否符合嚴格的安全基準方面發揮關鍵作用。隨著對安全有效醫療產品的需求不斷增加，生物安全測試市場也將不斷擴大，這得益於監管要求的不斷提高以及對公共健康和病人安全的日益關注。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

生物安全測試市場規模（依產品/服務及複合年成長率） (2025-2032)

• 市場概況
• 耗材
  • 黴漿菌檢測服務
  • 滅菌測試服務
  • 內毒素檢測服務
  • 病毒安全測試服務
  • 微生物附著量測試服務
• 裝置
• 服務
• 試劑和套件
• 其他生物安全檢測服務

生物安全測試市場規模（按測試類型和複合年成長率） (2025-2032)

• 市場概況
• 內毒素檢測
• 滅菌測試
• 黴漿菌檢測
• 微生物附著量測試
• 殘留宿主細胞蛋白質和 DNA 檢測測試
• 病毒安全測試
• 外來性病原體檢測
• 其他考試類型

生物安全測試市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 單株抗體開發與生產
• 疫苗研發和生產
• 細胞和基因治療產品的開發和製造
• 血液及血液製品的開發與生產
• 其他用途

生物安全測試市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 製藥和生物技術公司
• CRO＆CDMO
• 學術研究所

生物安全測試市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Charles River Laboratories（United States）
• Lonza Group（Switzerland）
• bioMerieux SA（France）
• SGS Societe Generale de Surveillance SA（Switzerland）
• Eurofins Scientific（Luxembourg）
• Samsung Biologics（South Korea）
• FUJIFILM Wako Pure Chemical Corporation（Japan）
• Thermo Fisher Scientific Inc.（United States）
• Sartorius AG（Germany）
• Merck KGaA（Germany）
• WuXi AppTec（China）
• Intertek Group plc（United Kingdom）
• West Pharmaceutical Services, Inc.（United States）
• Ajinomoto Bio-Pharma Services（United States）
• Gateway Analytical（United States）
• Reading Scientific Services Ltd.（RSSL）（United Kingdom）
• Tentamus Group（Germany）
• IQVIA（United States）

結論和建議

Biologics Safety Testing Market size was valued at USD 5.25 billion in 2023 and is poised to grow from USD 5.86 billion in 2024 to USD 14.21 billion by 2032, growing at a CAGR of 11.7% during the forecast period (2025-2032).

Biological safety testing is an essential process focused on ensuring the safety of biopharmaceuticals and medical devices derived from biological sources. This comprehensive approach aims to assess and mitigate potential risks by analyzing contamination and adverse biological effects. Adhering to stringent regulatory standards is crucial for confirming the purity, potency, and overall safety of these materials. Key techniques, including sterility testing, endotoxin assessment, and cell-based assays, play vital roles in evaluating compliance with rigorous safety benchmarks. As the demand for safe and effective medical products grows, the biological safety testing market is poised for expansion, driven by increasing regulatory requirements and a heightened focus on public health and patient safety.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biologics Safety Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biologics Safety Testing Market Segments Analysis

Global Biologics Safety Testing Market is segmented by Product and Services, Test Type, Application, End User and region. Based on Product and Services, the market is segmented into Consumables, Instruments, Services, Reagents and kits and Other Biologics Safety Testing Services. Based on Test Type, the market is segmented into Endotoxin tests, Sterility tests, Mycoplasma tests, Bioburden tests, Residual host-cell proteins and DNA detection tests, Virus safety tests, Adventitious agent detection tests and Other test types. Based on Application, the market is segmented into Monoclonal Antibodies Development And Manufacturing, Vaccines Development And Manufacturing, Cellular & Gene Therapy Products Development And Manufacturing, Blood & Blood Products Development And Manufacturing and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Cros & Cdmos and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biologics Safety Testing Market

Recent expansions in the pharmaceutical and biotechnology sectors, driven by significant investments in research and development, mark a critical phase in the evolution of healthcare. These industries are at the leading edge of developing pharmaceuticals, biologics, and vaccines, effectively tackling complex healthcare challenges, particularly in the fight against intricate diseases. This wave of innovation inherently heightens the demand for rigorous safety assessments, where biologics safety testing becomes essential in ensuring patient safety. As the landscape of healthcare continues to evolve, the importance of robust safety testing mechanisms will become increasingly vital in maintaining public health standards and fostering trust in new therapeutic solutions.

Restraints in the Biologics Safety Testing Market

The Biologics Safety Testing market faces several challenges that may hinder its growth. Key restraints include stringent regulatory requirements that can complicate the testing processes, alongside the high costs associated with developing and maintaining testing protocols. Furthermore, the constantly evolving landscape of biologics, coupled with the rapid advancement of biotechnology, necessitates ongoing updates in testing methodologies, which can be resource-intensive. Additionally, the limited availability of skilled professionals in the field may impede market expansion. These factors create significant hurdles for stakeholders aiming to navigate the complexities of biologics safety testing, ultimately affecting their ability to innovate and maintain compliance.

Market Trends of the Biologics Safety Testing Market

The Biologics Safety Testing market is experiencing significant growth, driven by intensified regulatory scrutiny on biopharmaceutical products, which emphasizes patient safety and product quality. As global regulatory bodies enforce stringent safety evaluations, biological safety testing has become essential for drug approvals, compelling pharmaceutical and biotech companies to prioritize compliance. This shift not only underscores the importance of comprehensive safety assessments but also stimulates heightened demand for specialized testing services. Consequently, the market is solidifying its position as a critical component in pharmaceutical development, ensuring that companies can navigate the complexities of regulatory requirements and achieve timely market entry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biologics Safety Testing Market Size by Product and Services & CAGR (2025-2032)

• Market Overview
• Consumables
  • Mycoplasma Testing Services
  • Sterility Testing Services
  • Endotoxin Testing Services
  • Virus Safety Testing Services
  • Bioburden Testing Services
• Instruments
• Services
• Reagents and kits
• Other Biologics Safety Testing Services

Global Biologics Safety Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Endotoxin tests
• Sterility tests
• Mycoplasma tests
• Bioburden tests
• Residual host-cell proteins and DNA detection tests
• Virus safety tests
• Adventitious agent detection tests
• Other test types

Global Biologics Safety Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Monoclonal Antibodies Development And Manufacturing
• Vaccines Development And Manufacturing
• Cellular & Gene Therapy Products Development And Manufacturing
• Blood & Blood Products Development And Manufacturing
• Other Applications

Global Biologics Safety Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Cros & Cdmos
• Academic & Research Institutes

Global Biologics Safety Testing Market Size & CAGR (2025-2032)

• North America (Product and Services, Test Type, Application, End User)
  • US
  • Canada
• Europe (Product and Services, Test Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product and Services, Test Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product and Services, Test Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product and Services, Test Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS Societe Generale de Surveillance SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Wako Pure Chemical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Bio-Pharma Services (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gateway Analytical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reading Scientific Services Ltd. (RSSL) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tentamus Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations